InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Gergen Mark J, Chief Executive Officer. Insider active across 1 company, notably Poseida Therapeutics, Inc.. Cumulatively, 2 filings have been recorded. History available since 1 February 2022. The latest transaction was filed on 1 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
357,200 shares0Common StockSEC:0001209191-22-006171:0
357,200 shares0Common StockSEC:0001209191-22-006171
2 of 2 declarations
About Gergen Mark J
Mark J. Gergen is the President and CEO of Poseida Therapeutics, Inc. He is responsible for the strategic direction of the company and the management of its operations. His expertise in the biopharmaceutical sector enables him to effectively guide the company towards sustainable growth.
